Editorial: Terlipressin and MDRO colonisation in cirrhosis-Is there a causal link?
- PMID: 38652777
- DOI: 10.1111/apt.17940
Editorial: Terlipressin and MDRO colonisation in cirrhosis-Is there a causal link?
Comment on
-
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis.Aliment Pharmacol Ther. 2024 Apr;59(7):877-888. doi: 10.1111/apt.17899. Epub 2024 Feb 27. Aliment Pharmacol Ther. 2024. PMID: 38414095
References
REFERENCES
-
- Dirchwolf M, Gomez Perdiguero G, Grech IM, Marciano S. Challenges and recommendations when selecting empirical antibiotics in patients with cirrhosis. World J Hepatol. 2023;15:377–385.
-
- Fernández J, Piano S, Bartoletti M, Wey EQ. Management of bacterial and fungal infections in cirrhosis: the MDRO challenge. J Hepatol. 2021;75(Suppl 1):S101–S117.
-
- Mücke MM, Hernández‐Tejero M, Gu W, Kuhn M, Janz M, Keller MI, et al. Terlipressin therapy is associated with increased risk of colonization with multidrug‐resistant bacteria in patients with decompensated cirrhosis. Aliment Pharmacol Ther.2024;59:877–888.
-
- Detsis M, Karanika S, Mylonakis E. ICU acquisition rate, risk factors, and clinical significance of digestive tract colonization with extended‐Spectrum Beta‐lactamase‐producing Enterobacteriaceae: a systematic review and meta‐analysis. Crit Care Med. 2017;45:705–714.
-
- Verma N, Divakar Reddy PV, Vig S, Angrup A, Biswal M, Valsan A, et al. Burden, risk factors, and outcomes of multidrug‐resistant bacterial colonisation at multiple sites in patients with cirrhosis. JHEP Rep. 2023;5:100788.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical